03:54 AM EDT, 05/20/2024 (MT Newswires) -- Virios Therapeutics ( VIRI ) said Sunday it has priced its previously announced public offering of 8.5 million common shares at $0.20 per share, for gross proceeds of about $1.7 million.

Net proceeds from the offering, which is set to close on Wednesday, will be used to begin preparatory activities for the company's planned IMC-2 Long-COVID Phase 2b study, as well as for general corporate purposes.

Price: 0.2449, Change: -0.11, Percent Change: -30.31